Arthritis  >>  diclofenac sodium topical  >>  Phase 3
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
diclofenac sodium topical / Generic mfg.
NCT00171626: Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis

Completed
3
480
US
Diclofenac Topical Sodium Gel 1%
Novartis
Osteoarthritis
06/05
06/05
NCT00171678: Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis

Completed
3
480
US
Diclofenac Topical Sodium Gel 1%
Novartis
Osteearthritis
08/05
08/05
NCT00171665: Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis

Completed
3
360
US
Diclofenac topical sodium gel 1%
Novartis
Osteoarthritis
 
12/05
NCT00171691: Safety of Diclofenac Sodium Gel in Knee Osteoarthritis

Completed
3
450
US
Diclofenac Topical Sodium Gel 1%
Novartis
Osteoarthritis
06/06
06/06
NCT01456611: Evaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1%

Completed
3
749
US
Diclofenac, Placebo
Anchen Pharmaceuticals, Inc, Novum Pharmaceutical Research Services
Osteo Arthritis of the Knee
04/12
04/12
NCT02596451: To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).

Completed
3
1164
US
Diclofenac Sodium gel, 1%, Voltaren® Gel, Placebo
Glenmark Pharmaceuticals Ltd. India
Osteoarthritis
03/16
03/16

Download Options